Cargando…

Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET

Following local and systemic treatment of gliomas, the differentiation between glioma relapse and treatment-related changes such as pseudoprogression or radiation necrosis using conventional MRI is limited. To overcome this limitation, various amino acid PET tracers such as O-[2-((18)F)-fluoroethyl]...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauer, Elena Katharina, Werner, Jan-Michael, Fink, Gereon R., Langen, Karl-Josef, Galldiks, Norbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635048/ https://www.ncbi.nlm.nih.gov/pubmed/34868923 http://dx.doi.org/10.3389/fonc.2021.735388

Ejemplares similares

Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
por: Galldiks, Norbert, et al.
Publicado: (2019)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
por: Rosen, Jurij, et al.
Publicado: (2021)

MLTI-17. DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS USING COMBINED FET PET/MRI RADIOMICS
por: Lohmann, Philipp, et al.
Publicado: (2019)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
por: Lohmann, Philipp, et al.
Publicado: (2018)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
por: Werner, Jan-Michael, et al.
Publicado: (2020)

Boosting the acceptance of (18)F-FET PET for image-guided treatment planning with a multi-centric prospective trial
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Feature-based PET/MRI radiomics in patients with brain tumors
por: Lohmann, Philipp, et al.
Publicado: (2021)

Adapting MR-BrainPET scans for comparison with conventional PET: experiences with dynamic FET-PET in brain tumours
por: Lohmann, Philipp, et al.
Publicado: (2014)

Evaluation of factors influencing (18)F-FET uptake in the brain
por: Verger, Antoine, et al.
Publicado: (2017)

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES
por: Galldiks, Norbert, et al.
Publicado: (2019)

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
por: Wollring, Michael M., et al.
Publicado: (2022)

Ability of Radiomics in Differentiation of Anaplastic Oligodendroglioma From Atypical Low-Grade Oligodendroglioma Using Machine-Learning Approach
por: Zhang, Yang, et al.
Publicado: (2019)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Advances in PET imaging for meningioma patients
por: Galldiks, Norbert, et al.
Publicado: (2023)

Use of advanced neuroimaging and artificial intelligence in meningiomas
por: Galldiks, Norbert, et al.
Publicado: (2022)

Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients
por: Friedrich, Michel, et al.
Publicado: (2022)

Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
por: Galldiks, Norbert, et al.
Publicado: (2016)

Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients
por: Lohmann, Philipp, et al.
Publicado: (2019)

Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy
por: Yu, Guangyang, et al.
Publicado: (2021)

PET/MRI Radiomics in Patients With Brain Metastases
por: Lohmann, Philipp, et al.
Publicado: (2020)

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume
por: Piroth, Marc D., et al.
Publicado: (2016)

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study
por: Garnier, Louis, et al.
Publicado: (2022)

Radiomics-Based Machine Learning Technology Enables Better Differentiation Between Glioblastoma and Anaplastic Oligodendroglioma
por: Fan, Yimeng, et al.
Publicado: (2019)

Congruency of tumour volume delineated by FET PET and MRSI
por: Mauler, Jörg, et al.
Publicado: (2015)

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression
por: Müller, Marguerite, et al.
Publicado: (2022)

Genetic landscape of extreme responders with anaplastic oligodendroglioma
por: Holdhoff, Matthias, et al.
Publicado: (2017)

TCF12 is mutated in anaplastic oligodendroglioma
por: Labreche, Karim, et al.
Publicado: (2015)

Multiple Extraneural Metastases of Anaplastic Oligodendroglioma
por: Aydemir, Fatih, et al.
Publicado: (2018)

A rare, giant, anaplastic oligodendroglioma
por: Tuan, Pham Anh, et al.
Publicado: (2023)

Combined (18)F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes
por: D’Amore, Francesco, et al.
Publicado: (2021)

Sequential implementation of DSC-MR perfusion and dynamic [(18)F]FET PET allows efficient differentiation of glioma progression from treatment-related changes
por: Steidl, Eike, et al.
Publicado: (2020)

Anaplastic oligodendroglioma presenting with apoplectic intratumoral hemorrhage
por: Yoshida, Kohei, et al.
Publicado: (2022)

A Rare Presentation of Multifocal Anaplastic Oligodendroglioma
por: Reddy, Ravikanth
Publicado: (2022)

Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
por: Galldiks, Norbert, et al.
Publicado: (2012)

Current status of PET imaging in neuro-oncology
por: Galldiks, Norbert, et al.
Publicado: (2019)

The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
por: Galldiks, Norbert, et al.
Publicado: (2016)

Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
por: Werner, Jan-Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rsvcr8ucbkcjagb8bjbjr34keq